Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Effect of Crocus sativus L. on Expression of VEGF-A and VEGFR-2 Genes (Angiogenic Biomarkers) in MCF-7 Cell Line

Marzeih Mousavi 1 and Javad Baharara 1 , *
Authors Information
1 Research Center for Animal Development Applied Biology, Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: November 28, 2014, 16 (12); 9-15
  • Published Online: November 20, 2013
  • Article Type: Research Article
  • Received: November 23, 2013
  • Accepted: November 15, 2013

To Cite: Mousavi M, Baharara J. Effect of Crocus sativus L. on Expression of VEGF-A and VEGFR-2 Genes (Angiogenic Biomarkers) in MCF-7 Cell Line, Zahedan J Res Med Sci. 2014 ; 16(12):9-15.

Copyright © 2014 Zahedan University of Medical Sciences. All rights reserved.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Materials and Methods
  • 1. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med. 2003; 3(7): 643-51[PubMed]
  • 2. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature. 2005; 438(7070): 967-74[DOI][PubMed]
  • 3. Hendrix M, Seftor E, Seftor R. New Frontiers in Angiogenesis. 2006; : 97-109[DOI]
  • 4. Fayette J, Soria JC, Armand JP. Use of angiogenesis inhibitors in tumour treatment. Eur J Cancer. 2005; 41(8): 1109-16[DOI][PubMed]
  • 5. Breier G, Unsicker K, Kriegistein K. Vasculogenesis in cell signaling and growth factors in development. 2006; : 909-17
  • 6. Guo S, Colbert LS, Fuller M, Zhang Y, Gonzalez-Perez RR. Vascular endothelial growth factor receptor-2 in breast cancer. Biochim Biophys Acta. 2010; 1806(1): 108-21[DOI][PubMed]
  • 7. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006; 7(5): 359-71[DOI][PubMed]
  • 8. Rahimi N. VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy. Front Biosci. 2006; 11: 818-29[PubMed]
  • 9. Solowiej J, Bergqvist S, McTigue MA, Marrone T, Quenzer T, Cobbs M, et al. Characterizing the effects of the juxtamembrane domain on vascular endothelial growth factor receptor-2 enzymatic activity, autophosphorylation, and inhibition by axitinib. Biochemistry. 2009; 48(29): 7019-31[DOI][PubMed]
  • 10. Singh AJ, Meyer RD, Band H, Rahimi N. The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation. Mol Biol Cell. 2005; 16(4): 2106-18[DOI][PubMed]
  • 11. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004; 56(4): 549-80[DOI][PubMed]
  • 12. Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM. Molecular interactions in cancer cell metastasis. Acta Histochem. 2010; 112(1): 3-25[DOI][PubMed]
  • 13. Bhat TA, Singh RP. Tumor angiogenesis--a potential target in cancer chemoprevention. Food Chem Toxicol. 2008; 46(4): 1334-45[DOI][PubMed]
  • 14. Kummalue T. Molecular mechanism of herbs in human lung cancer cells. J Med Assoc Thai. 2005; 88(11): 1725-34[PubMed]
  • 15. Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast cancer in Iran: an epidemiological review. Breast J. 2007; 13(4): 383-91[DOI][PubMed]
  • 16. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev. 2004; 5(1): 24-7[PubMed]
  • 17. Cristofanilli M, Broglio KR, Guarneri V, Jackson S, Fritsche HA, Islam R, et al. Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer. 2007; 7(6): 471-9[PubMed]
  • 18. Rudel RA, Fenton SE, Ackerman JM, Euling SY, Makris SL. Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations. Environ Health Perspect. 2011; 119(8): 1053-61[DOI][PubMed]
  • 19. Fernandez JA. Biology, biotechnology and biomedicine of saffron. Recent Res Dev Plant Sci. 2004; 2: 127-59
  • 20. Kaefer CM, Milner JA. The role of herbs and spices in cancer prevention. J Nutr Biochem. 2008; 19(6): 347-61[DOI][PubMed]
  • 21. Abdullaev FI, Espinosa-Aguirre JJ. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev. 2004; 28(6): 426-32[DOI][PubMed]
  • 22. Melnyk JP, Wang S, Marcone MF. Chemical and biological properties of the world's most expensive spice: Saffron. Food Res Int. 2010; 43(8): 1981-9[DOI]
  • 23. Abdullaev FI. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp Biol Med (Maywood). 2002; 227(1): 20-5[PubMed]
  • 24. Ochiai T, Shimeno H, Mishima K, Iwasaki K, Fujiwara M, Tanaka H, et al. Protective effects of carotenoids from saffron on neuronal injury in vitro and in vivo. Biochim Biophys Acta. 2007; 1770(4): 578-84[DOI][PubMed]
  • 25. Premkumar K, Thirunavukkarasu C, Abraham SK, Santhiya ST, Ramesh A. Protective effect of saffron (Crocus sativus L.) aqueous extract against genetic damage induced by anti-tumor agents in mice. Hum Exp Toxicol. 2006; 25(2): 79-84[PubMed]
  • 26. Jessie SW, Krishnakantha TP. Inhibition of human platelet aggregation and membrane lipid peroxidation by food spice, saffron. Mol Cell Biochem. 2005; 278(1-2): 59-63[DOI][PubMed]
  • 27. Dhar A, Mehta S, Dhar G, Dhar K, Banerjee S, Van Veldhuizen P, et al. Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model. Mol Cancer Ther. 2009; 8(2): 315-23[DOI][PubMed]
  • 28. Hosseinpour Chermahini S, Abd F, Sarmadi M. Impact of saffron as an anti-cancer and anti-tumor herb. Afr J Pharm Pharmacol. 2010; 4(11): 834-40
  • 29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4): 402-8[DOI][PubMed]
  • 30. Das I, Chakrabarty RN, Das S. Saffron can prevent chemically induced skin carcinogenesis in Swiss albino mice. Asian Pac J Cancer Prev. 2004; 5(1): 70-6[PubMed]
  • 31. Schmidt M, Betti G, Hensel A. Saffron in phytotherapy: pharmacology and clinical uses. Wien Med Wochenschr. 2007; 157(13-14): 315-9[DOI][PubMed]
  • 32. Chryssanthi DG, Lamari FN, Iatrou G, Pylara A, Karamanos NK, Cordopatis P. Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Res. 2007; 27(1A): 357-62[PubMed]
  • 33. Nabavizadeh F, Salimi E,, Sadroleslami Z. Saffron (Crocus sativus) increases gastric acid and pepsin secretions in rats: Role of nitric oxide (NO). Afr J Pharm Pharmacol. 2009; 3(5): 181-4
  • 34. Mousavi SH, Brook A, Tavakol Afshari J. Study of cytotoxic effects of saffron in MCF-7 cells. Iran J Pharmaceutical Sci. 2008; 4(4): 261-8
  • 35. Ochiai T, Soeda S, Ohno S, Tanaka H, Shoyama Y, Shimeno H. Crocin prevents the death of PC-12 cells through sphingomyelinase-ceramide signaling by increasing glutathione synthesis. Neurochem Int. 2004; 44(5): 321-30[PubMed]
  • 36. Holloway GM, Gainer JL. The carotenoid crocetin enhances pulmonary oxygenation. J Appl Physiol (1985). 1988; 65(2): 683-6[PubMed]
  • 37. Martin G, Goh E, Neff AW. Evaluation of the developmental toxicity of crocetin on Xenopus. Food Chem Toxicol. 2002; 40(7): 959-64[PubMed]
  • 38. Aung HH, Wang CZ, Ni M, Fishbein A, Mehendale SR, Xie JT, et al. Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp Oncol. 2007; 29(3): 175-80[PubMed]
  • 39. Feizzadeh B, Afshari JT, Rakhshandeh H, Rahimi A, Brook A, Doosti H. Cytotoxic effect of saffron stigma aqueous extract on human transitional cell carcinoma and mouse fibroblast. Urol J. 2008; 5(3): 161-7[PubMed]
  • 40. Mousavi SH, Tavakkol-Afshari J, Brook A, Jafari-Anarkooli I. Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells. Food Chem Toxicol. 2009; 47(8): 1909-13[DOI][PubMed]
  • 41. Tavakkol-Afshari J, Brook A, Mousavi SH. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem Toxicol. 2008; 46(11): 3443-7[DOI][PubMed]
  • 42. Tugues S, Koch S, Gualandi L, Li X, Claesson-Welsh L. Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer. Mol Aspects Med. 2011; 32(2): 88-111[DOI][PubMed]
  • 43. Saharinen P, Eklund L, Pulkki K, Bono P, Alitalo K. VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol Med. 2011; 17(7): 347-62[DOI][PubMed]
  • 44. Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol. 2009; 21(2): 154-65[DOI][PubMed]
  • 45. Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN. Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci. 2006; 27(6): 297-309[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments